Endo International | ENDP - Ebit



Ebit Veränderung Datum
AbbVie USD 4.73B 1.08B 2026-03
Amarin USD -2.26M 564K 2025-12
ANI Pharmaceuticals USD 38.71M 9.58M 2026-03
Bristol-Myers Squibb USD 3.56B 90M 2026-03
Coherus Biosciences USD -39.08M 3.65M 2025-12
Eli Lilly USD 9.78B 792M 2026-03
Heron Therapeutics USD 38K 3.83M 2025-12
Hikma Pharmaceutical USD 348M 31M 2025-12
Ligand Pharmaceuticals USD 60.33M 1.76M 2026-03
Merck USD -1.88B 8.12B 2026-03
Novartis USD 4.18B 118M 2026-03
Pacira USD 4.62M 1.43M 2026-03
Perrigo USD 33.6M 50.8M 2026-03
Pfizer USD 4.99B 340M 2026-03
Phibro Animal Health USD 54.99M 2.36M 2025-12
Supernus Pharmaceuticals USD -35.25M 49.07M 2026-03
Takeda JPY -13.62B 271.11B 2026-03
Teva Pharmaceutical Industries USD 758M 181M 2026-03
Xeris Pharmaceuticals USD 9.12M 7.65M 2026-03
Zoetis USD 842M 7M 2026-03